Celyad focuses on translating promising research into transformative treatments aimed at reversing the outcome of severe diseases. Celyad identifies and further advances therapeutic solutions that have the potential to change the lives of thousands of patients worldwide.
Our scientific approach is inspired by natural mechanisms that are used by the body to fight disease. We put all our efforts into developing and delivering best-in-class therapies that will re-engage these natural mechanisms in patients. We know that every second counts for patients, this is what drives us in our work every day.

Type
Public
HQ
Mont-Saint-Guibert, BE
Founded
2007
Employees
82 (est)

Celyad Locations

Mont-Saint-Guibert, BE
Boston, US

Celyad Metrics

Celyad Summary

Founding Date

2007

Market capitalization

€172 B

Closing share price

€17

Celyad Market Value History

Celyad Company Life